Dr. Yang founded Apexigen in July of 2010, and serves as President, CEO and a member of the board of directors. Prior to forming Apexigen, he served as Vice President of R&D at Intradigm Corporation (now Silence Therapeutics). Dr. Yang began his career as a founding scientist at Abgenix, Inc. (now Amgen) where he was Senior Director and headed the Oncology Therapeutic Program Team responsible for setting strategy and managing the company’s oncology portfolio and partnerships. While at Abgenix he served as the project team leader for Vectibix ® (panitumumab) and played a key role in its discovery, development and BLA approval.